Profile data is unavailable for this security.
About the company
Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.
- Revenue in HKD (TTM)0.00
- Net income in HKD-617.47m
- Incorporated2012
- Employees472.00
- LocationJiangsu Recbio Technology Co LtdNo. 888 Yaocheng AvenueChina Medical CityTAIZHOU ChinaCHN
- Phone+86 52 386818860
- Websitehttps://www.recbio.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Golden Throat Holdings Group Co Ltd | 1.04bn | 270.07m | 2.33bn | 869.00 | 8.62 | 1.39 | 7.46 | 2.24 | 0.3653 | 0.3653 | 1.40 | 2.26 | 0.4181 | 4.82 | 1.85 | 1,194,336.00 | 10.88 | 11.00 | 15.85 | 15.63 | 72.57 | 72.79 | 26.02 | 24.67 | 2.48 | 34.74 | 0.21 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
| Cutia Therapeutics | 148.57m | -2.12bn | 2.34bn | 298.00 | -- | 1.61 | -- | 15.76 | -6.97 | -6.97 | 0.4887 | 4.79 | -- | -- | -- | 498,571.20 | -- | -- | -- | -- | 51.60 | -- | -1,426.91 | -- | 5.38 | -- | 0.153 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -617.47m | 4.34bn | 472.00 | -- | 3.72 | -- | -- | -1.28 | -1.28 | 0.00 | 2.41 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 667.32m | -128.88m | 4.59bn | 813.00 | -- | 3.22 | -- | 6.88 | -0.2531 | -0.2531 | 1.31 | 2.80 | 0.2732 | 1.35 | 2.53 | 820,806.90 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Ocumension Therapeutics | 265.97m | -410.01m | 4.68bn | 444.00 | -- | 1.48 | -- | 17.60 | -0.6319 | -0.6319 | 0.4097 | 4.56 | 0.078 | 3.61 | 2.12 | 599,034.80 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -269.19m | 4.73bn | 133.00 | -- | 4.33 | -- | -- | -1.35 | -1.35 | 0.00 | 5.44 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 2.80bn | 846.96m | 4.81bn | 3.13k | 5.38 | 1.18 | 5.16 | 1.72 | 1.06 | 1.06 | 3.50 | 4.83 | 0.4981 | 2.08 | 10.05 | 894,218.40 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.32m | 4.85bn | 2.87k | -- | 1.01 | -- | 2.41 | -0.0063 | -0.0063 | 0.216 | 0.5128 | 0.1572 | 0.8101 | 4.72 | 699,369.60 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 873.63m | 110.32m | 5.46bn | 948.00 | 16.32 | 0.712 | -- | 6.26 | 0.1072 | 0.1072 | 0.8296 | 2.46 | 0.2852 | 1.44 | 1.62 | 921,547.10 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | -- |
| Everest Medicines Ltd | 135.95m | -911.66m | 6.11bn | 432.00 | -- | 1.12 | -- | 44.92 | -2.92 | -2.92 | 0.4343 | 16.80 | 0.0203 | 2.25 | 4.57 | 314,705.80 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
Data as of Jul 24 2024. Currency figures normalised to Jiangsu Recbio Technology Co Ltd's reporting currency: Hong Kong Dollar HKD
3.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lake Bleu Capital (Hong Kong) Ltd.as of 20 Feb 2023 | 11.30m | 3.57% |
Data from 05 Jun 2024 - 05 Jun 2024Source: FactSet Research Systems Inc.
